EP3678649
Nefholsadrenalínsamsetningar og aðferðir til að meðhöndla sjúkdóm
:
EP einkaleyfi í gildi á Íslandi:
6.2.2019:
26.10.2022:
19751807.9
:
9.1.2023:
15.2.2023
:
5.2.2039:
5.2.2026:
28.2.2026
:
INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
6.2.2019
26.10.2022
9.1.2023
15.2.2023
5.2.2026
:
Aegis Therapeutics, LLC:
3430 Carmel Mountain Road, Suite 300, San Diego CA 92121, US
:
ARS Pharmaceuticals Operations, Inc.:
11682 EL Camino Real, Suite 120, San Diego, California 92130, US
:
LOWENTHAL, Richard:
San Diego, California 92127, US
:
MAGGIO, Edward T.:
San Diego, California 92121, US
:
BELL, Robert G.:
San Diego, California 92127, US
:
SHAH, Pratik:
San Diego, California 92127, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201815890131:
6.2.2018:
US
:
201862784057 P:
21.12.2018:
US
:
201862685049 P:
14.6.2018:
US
:
201862734550 P:
21.9.2018:
US
:
US2019016918:
6.2.2019
:
SPC500
:
A61K 31/137, A61K 9/08, A61K 47/26, A61P 27/14
: 5
: 19.12.2022
: 5.2.2024
: Árnason Faktor ehf.
: 6
: 18.1.2024
: 5.2.2025
: Árnason Faktor ehf.
: 7
: 20.1.2025
: 5.2.2026
: Árnason Faktor ehf.